Recent Headlines
Within Biotechnology
National Institutes of Health Award a $1.7M SBIR Grant to MicroTransponder to Develop a Neurostimulation-Based Therapy to Treat Tinnitus
MicroTransponder, Inc., a privately-held medical device company, announced that it has been awarded a $1.7M SBIR grant from the National Institute on Deafness and Other Communication Disorders (NIDCD) to develop a neurostimulation-based therapy for the treatment of Tinnitus. This project builds... - September 01, 2010 - MicroTransponder Inc.
AnaSpec Signs Distribution Agreement with Interprise Brasil
AnaSpec, Inc. and Interprise Brasil today announced a non-exclusive distributor agreement that will allow Interprise Brasil to distribute AnaSpec’s catalog and custom products throughout Brasil. - August 28, 2010 - AnaSpec, EGT Group
CW Optics Announces Clinical Trial of Breakthrough Technology for Wound Imaging for Diabetics
CW Optics, Inc. announced today a clinical trial at Richmond's Chippenham and Johnston-Willis (CJW) Medical Center to investigate the safety and efficacy of WoundImager®, an advanced optical imaging device for monitoring the effectiveness of therapeutic management of chronic wounds caused by... - August 27, 2010 - CW Optics, Inc.
CW Optics Announces Clinical Trial of Breakthrough Technology for the Detection of Intravenous Infiltration
CW Optics, Inc. announced today the launch of a clinical trial at the Virginia Commonwealth University Health System to investigate the safety and efficacy of ivWatch®, a novel optical device for monitoring intravenous (IV) infusion sites for infiltration. Each year, there are approximately 150... - August 27, 2010 - CW Optics, Inc.
Bio-Med QC Offers an Indiana Pharmacy Exclusive
Bio-Med QC has recently designed the most comprehensive and the most effective CSP quality assurance microbiology system available. The Bio-Shield AT system includes added value, on site training and saves you money over the alternative options that provide no microbiology support. Bio-Med QC has... - August 26, 2010 - Bio-Med QC
AnaSpec Visits with Noted Alzheimer’s Researcher, Dr. Patrick McGeer
AnaSpec’s general manager, Dr. Anita Hong and technical support specialist, Cecilia Po, visited the highly published and eminent Alzheimer’s researcher, Dr. Patrick McGeer and his associate, Dr. Jian-Ping Guo at the University of British Columbia, Vancouver, Canada on Aug. 12, 2010. - August 22, 2010 - AnaSpec, EGT Group
Strand and Narayana Hrudalaya Collaborate in Translational Cancer Research
First-of-its kind project in translational cancer research aimed to produce pioneering discoveries and affordable clinical solutions in cancer care. - August 21, 2010 - Strand Life Sciences Pvt. Ltd.
The Porcine microRNAome is Revealed
Results blaze a trail for advancement in pig biology as well the use of pigs as model organism for human biological and biomedical studies - August 20, 2010 - LC Sciences LLC
AnaSpec Introduces SensoLyte® Biotin Quantitation Assay Kit
AnaSpec is pleased to announce the release of the FRET based biotin quantitation kit. The SensoLyte® Biotin Quantitation Assay Kit provides a convenient way to estimate the efficiency of biotinylation for biotin-protein conjugates. The kit also can be used in quantitate biotin concentration in a solution. - August 20, 2010 - AnaSpec, EGT Group
CHI’s BioPharma Strategy Series Presents the Inaugural Mitigating Safety Risks in Early Clinical Development Executive Forum November 8-9, 2010, Philadelphia, PA
Presentations Discuss Bridging the Gap Between Pre-Clinical and Clinical Safety to Improve Prediction. - August 20, 2010 - Cambridge Healthtech Institute
CEO Will Rosellini and MicroTransponder Inc. Named Finalists for the 10th Annual Tech Titans Awards
The MTBC has named CEO Will Rosellini a finalist for the Tech Innovator category and MicroTransponder a finalist for the Emerging Company Horizon category for the 10th Annual Tech Titan Awards in Texas. - August 17, 2010 - MicroTransponder Inc.
Bioo Scientific Chooses Eureka Genomics as Its Next-Generation Sequencing Provider
Bioo Scientific selected Eureka Genomics as its next-generation sequencing service provider. - August 17, 2010 - Bioo Scientific
Clinical Trials in Russia. 2nd Quarter 2010.
The Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation (alias RosZdravNadzor, RZN) approved 178 new clinical trials of all types including local and bioequivalence studies during the second quarter of 2010 demonstrating a 38% increase over the corresponding period of last year. - August 14, 2010 - Synergy Research Group
AnaSpec Introduces Speedy 28-Day Antibody Service
AnaSpec introduces the Speedy 28-day custom polyclonal antibody service. Leveraging proven technology from Eurogentec, AnaSpec's parent company, this protocol uses a proprietary mixture of Freund's free immuno-stimulatory compounds. The first bleed, obtained at the accelerated rate of Day 21 after... - August 11, 2010 - AnaSpec, EGT Group
NSF Funds Innovative Approach to Biomimetic Nanofiber Bone Regeneration
Dr. Hongjun Wang at Stevens Institute of Technology investigates a new bottom-up approach to tissue engineering. - August 06, 2010 - Stevens Institute of Technology
Colorado BioScience Association Seeks Region’s Top Innovators for Venture Showcase Competition at 2010 BioWest Conference & Expo
The organizers of the annual BioWest Conference & Expo are again looking for the best bioscience start-ups in the region as candidates for this year's $7,500 Dorsey & Whitney Venture Showcase Award. Four companies will be chosen to present at the showcase on Wednesday, September 29, 2010, and will be judged by a panel of venture capitalists. Deadline for entry is Friday, August 20. - August 04, 2010 - Colorado BioScience Association
Novus Biologicals Releases Two New Posters to Guide Antibody Research
Novus revealed two new posters at the ISSCR 8th Annual Meeting between June 16 - 19 – a fluorescent labels poster and a stem cell signalling pathway poster. The fluorescent labels poster displays all fluorophores that Novus offers conjugated to their primary antibodies. The stem cell... - August 04, 2010 - Novus Biologicals Europe
NSF Funds Building a Creativity Collective: Using the Crowd to Solve Societal Problems
Stevens Professors Nickerson and Sakamoto are funded by the National Science Foundation to research crowdsourcing and the creative collective. - July 30, 2010 - Stevens Institute of Technology
International Stem Cell Corporation Planning European Subsidiary
International Stem Cell Corporation (OTCBB:ISCO) announced that it had entered into a Memorandum of Understanding with ARG Vermogensverwaltung AG ('ARG'), a German Investment Fund, to create a new European subsidiary ('ISCO Europe') to be funded with up to $10 million of capital derived from ARG... - July 28, 2010 - International Stem Cell Corporation
ALPCO Diagnostics Launches First Commercially Available Sclerostin ELISA in the U.S.
ALPCO Diagnostics recently launched an ELISA specific for measuring human sclerostin in serum and plasma. Sclerostin inhibits osteoblast activity via antagonism of the wnt signaling pathway and plays a key role in the regulation of bone formation. Reports show that sclerostin expression and/or... - July 27, 2010 - ALPCO
Bioo Scientific Releases the ExoMir™ Kit to Facilitate RNA Analysis in Cell-Free Fluids
Bioo Scientific’s new ExoMir™ kit simplifies the fractionation of and RNA extraction from exosomes and other microparticles in cell-free fluids. - July 26, 2010 - Bioo Scientific
Stevens Hosts 2010 Metro Area NEMS/MEMS Workshop
Nanomanufacturing Workshop hosted by Stevens Institute of Technology on Monday, July 26th in Hoboken, New Jersey. - July 24, 2010 - Stevens Institute of Technology
Health Decisions Appoints New CTO to Streamline Its HD360° Trial Management Platform
CRO hires Bryan Minihan to boost data integration and flow, providing sponsors and sites with a one-stop web portal for near real-time study information. - July 24, 2010 - Health Decisions
ALN Publishes Article on Whole Animal Database by Noesys Data
Article on Artios Software Suite is published by ALN, a respected industry publication covering animal research institutions and markets. - July 21, 2010 - Noesys Data
AnaSpec’s Published References Pass 1000
As compiled by Stanford University’s Highwire Press, the number of published papers that cite AnaSpec’s products has passed 1000. Products cited include AnaSpec’s custom and catalog peptides, antibodies, assay kits, dyes, standard amino acids, unusual amino acids and synthesis... - July 21, 2010 - AnaSpec, EGT Group
NSF Funds Infection-Resistant Orthopedic Research
Researchers at Stevens explore inkjet printing of drug-eluting, bioresorbable micropatterns onto the surface of orthopedic implants to prevent bacterial infection of the implants. - July 21, 2010 - Stevens Institute of Technology
Wockhardt Foundation Achieves Another Milestone - Over 200 Cleft Surgeries in Association with Smile Train
Wockhardt Foundation, in collaboration with Smile train has successfully completed over 200 surgeries. - July 18, 2010 - Wockhardt Foundation
200,000 Patients Screened by Wockhardt Foundation Within 200 Days
Wockhardt Foundation screens over 200,000 patients. - July 18, 2010 - Wockhardt Foundation
InnoCore and Nanomi Strengthen Collaboration in Microsphere Technology for Peptide and Protein Delivery
InnoCore Technologies BV and Nanomi BV announce a strategic collaboration for the development of advanced monodisperse biodegradable microsphere-based controlled release formulations for the sustained delivery of biotherapeutics. - July 14, 2010 - Nanomi
International Stem Cell Corp. and India's Largest Eye Hospital to Develop Stem Cell-Based Treatment for Corneal Vision Impairment
International Stem Cell Corporation and Sankara Nethralaya Eye Hospital, a nonprofit medical facility, are collaborating to develop ISCO's 'CytoCor™' stem cell-derived corneal tissue. The goal is to use CytoCor, human tissue derived from pluripotent human stem cells, to treat corneal blindness and vision impairment. - July 11, 2010 - International Stem Cell Corporation
NanoLetters Publishes Dr. Yong Shi’s Energy Harvesting Technology
Dr. Shi’s research focuses on miniature energy harvesting technologies that could potentially power wireless electronics, portable devices, stretchable electronics, and implantable biosensors. - July 11, 2010 - Stevens Institute of Technology
The NIH Awards Aciont® a Small Business Catalyst Award Grant Accelerating Innovative Research
Aciont is awarded a phase I SBIR $214K grant for the project titled “Novel Method for the Ocular Iontophoretic Delivery of Avastin® and Lucentis®.” - July 08, 2010 - Aciont Inc.
Wockhardt Foundation Awarded ‘Pharma CSR Organization of the Year 2010’
Wockhardt Foundation wins the CSR award under the leadership of Huzaifa Khorakiwala who through his Human Values has created a team of dedicated warriors to work towards the upliftment of the poor weak and needy. - July 02, 2010 - Wockhardt Foundation
Stemedica Announces the Appointment of Dr. Cesar Amescua Garcia as Medical and Regulatory Affairs Director – Latin America
Dr. Amescua will be responsible for liaison with regulatory agencies in Latin America regarding approvals of Stemedica’s allogeneic adult stem cell products for use in clinical (human) trials which follow the criteria required by the FDA in the United States. - July 02, 2010 - Stemedica Cell Techechnologies
Red Cedar Technology Expands Business Development Team
Angelo Flemings joins Red Cedar Technology as Director of Business Development. - July 02, 2010 - Red Cedar Technology
Red Cedar Technology Elects New Board Chairman
Robert Ryan Joins Red Cedar Technology's Leadership Team. - July 02, 2010 - Red Cedar Technology
Consumers Report Positive Results in Reducing Symptoms of Lactose Intolerance with Lactagen
Customer Experience Reports indicate relief from the symptoms of lactose intolerance using the Lactagen® program of colonic adaptation. - July 02, 2010 - Lactagen
Colorado BioScience Association Commends Boettcher Foundation on Historic Launch of Webb-Waring Biomedical Research Program & Inaugural Class of 'Boettcher Investigators'
Colorado BioScience Association commends Boettcher Foundation on launching the new Webb-Waring Biomedical Research Program and its 2010 (Inaugural) Class of Boettcher Investigators. This new grant program will ensure that the Webb-Waring legacy lives on both through the discovery of new knowledge that improves human health and through the investment in and advancement of early-career scientists. - July 01, 2010 - Colorado BioScience Association
The 5th BIO KOREA 2010, Korea’s Largest Exhibition & Conference, on Biotech in Seoul, 1-3 September
The 5th BIO KOREA 2010 Conference & Exhibition will be held from September 1 to 3, 2010 at COEX in Seoul/Korea. BIO KOREA of this year offers a variety of high-level conference, international exhibition and partnership events and provides an opportunity to find business and technology partners. It expects to 265 companies and about 19,000 visitors from across the globe. - June 29, 2010 - Bio Korea
Functional Genetics Announces Two Separate Awards from the National Institute of Allergy and Infectious Diseases to Develop Broad Spectrum Antivirals
Functional Genetics, Inc. today announced the awarding of two different Phase II SBIR awards from the National Institute of Allergy and Infectious Diseases (NIAID) to pursue innovative approaches for antibody-based targeting of infectious diseases. Under the terms of the agreement, Functional... - June 29, 2010 - Functional Genetics, Inc.
Dr. Mitola and Cognitive Radio Are Featured on Computing Now
Dr. Joseph Mitola III, Vice President for the Research Enterprise at Stevens Institute of Technology, is the subject of a recent article on Computing Now which details the benefits and development of Cognitive Radio (CR), the intelligent wireless technology coined by Dr. Mitola in... - June 25, 2010 - Stevens Institute of Technology
ONR Continues Major Funding of ACCeSS Research Center at Stevens
The Atlantic Center for the Innovative Design and Control of Small Ships (ACCeSS) at Stevens Institute of Technology announced major funding for the next five years worth $4.5 million by the Office of Naval Research (ONR) as part of its National Naval Responsibility – Naval Engineering... - June 24, 2010 - Stevens Institute of Technology
Economic Development Executive Holli Baumunk Named President & CEO of the Colorado BioScience Association Effective July 12
Holli Baumunk, Vice President of the Metro Denver Economic Development Corporation for the past seven years, has been named President & CEO of the Colorado BioScience Association (CBSA) July 12. The announcement is made by Rick Jory, CBSA Board Chairperson, who says Baumunk was unanimously... - June 24, 2010 - Colorado BioScience Association
NSF Funds Mathematical Research at Stevens
Dr. Alexei Miasnikov, Dr. Robert Gilman and Alexander Ushakov of Stevens Institute of Technology were recently awarded NSF funding that enables them to organize the thematic semester on geometric, combinational and computational group theory at the Centre de Recherches Mathmatiques (CRM) in Montreal. - June 23, 2010 - Stevens Institute of Technology
Dr. Mitola Delivered Keynote at CrownCom 2010
On June 9th - 11th 2010, in Cannes, France, Dr. Joseph Mitola III, Vice President for the Research Enterprise at Stevens Institute of Technology, delivered a keynote address at the CrownCom 2010 International Conference on Cognitive Radio Oriented Wireless Networks and Communication. - June 19, 2010 - Stevens Institute of Technology
AnaSpec Introduces New SensoLyte® uPA & tPA Assay Kits
AnaSpec is pleased to introduce two plasminogen activator assay kits – the SensoLyte AFC Urokinase (uPA) Assay Kit and the SensoLyte AMC tPA Assay Kit. - June 19, 2010 - AnaSpec, EGT Group
Advanced Cell Technology Awarded Broad Patent for Production of Retinal Pigment Epithelial Cells
This broad patent gives Advanced Cell Technology the opportunity to have a monopoly around embryonic stem cells derived from RPE cells. There are over 200 diseases and conditions which potentially be treated with RPE-derived cells. - June 18, 2010 - Advanced Cell Technology, Inc.
AnaSpec Signs Distribution Agreement with Bioeasy Diagnostica
AnaSpec, Inc. and Bioeasy Diagnostica today announced a non-exclusive distributor agreement that will allow Bioeasy Diagnostica to distribute AnaSpec’s catalog and custom products throughout Brasil. AnaSpec’s Director of Sales & Marketing, Violeta Rajkovska, noted, “AnaSpec... - June 18, 2010 - AnaSpec, EGT Group
BIOCIUS Life Sciences and BlueSky Biotech Extend Partnership, Provide Validated Enzymes Fully‐Validated SIRT1 Enhances Drug Discovery Investigation
BIOCIUS Life Sciences Inc., developers of the RapidFire® highthroughputmass spectrometry system, and BlueSky Biotech, service provider of discovery biologicals, today announced their collaboration to offer the industry’s only Sirtuin (SIRT, silent mating type information regulation... - June 18, 2010 - Blue Sky Biotech
ALPCO Diagnostics Exclusively Offers Animal NGAL Assays from BioPorto
BioPorto Diagnostics has awarded ALPCO Diagnostics exclusive distributorship for its animal NGAL ELISAs to the North American market. BioPorto’s prominence is unrivaled in immunoassays for measuring NGAL (neutrophil gelatinase associated lipocalin) – the breakthrough kidney injury... - June 17, 2010 - ALPCO